Depo-Medrol with Lidocaine; Depo-Medrone with Lidocaine

Pfizer Inc

Revision date : 2009-08-19

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

100-51-6

Name of the chemical

Benzyl Alcohol

Concentration

N/A

EC/CAS

25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

N/A

EC/CAS

7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

EC/CAS

202-859-9

Name of the chemical

Benzyl alcohol (38)

Concentration

N/A

EC/CAS

231-791-2

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

General Information

Revision date

2009-08-19

Product name

Depo-Medrol with Lidocaine; Depo-Medrone with Lidocaine

Emergency telephone

(24 hours) 1-800-424-9300

Icons in SDS

Company Information

company name

Pfizer Inc

e-mail address of the competent person responsible for the Safety Data Sheet

pfizer-MSDS@pfizer.com

GHS Information

Signal word

DANGER

Section 2

SECTION 2: Hazards identification

Appearance: White suspension

Signal word

DANGER

Hazard statements

May damage the unborn child.

Additional information

Short Term: May be harmful if absorbed through the skin. May cause numbing effects to skin . Accidental ingestion may cause effects similar to those seen in clinical use. May produce allergic reactions following skin contact. (based on animal data) . Long Term: Animal studies have shown a potential to cause adverse effects on the fetus. Repeat-dose studies in animals have shown a potential to cause adverse effects on blood and blood forming organs Known Clinical Effects: Adverse clinical reactions include the development of hypersensitivity and/or irritation leading to rashes, itching, and burning. Clinical use has resulted in hormonal alterations. Clinical use has resulted in changes in electrolytes and/or blood chemistry changes. EU Indication of danger: Toxic to reproduction: Category 1 EU Hazard Symbols: EU Risk Phrases: R61 - May cause harm to the unborn child. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.